Go Pro

Cantor Fitzgerald's Rating of Trulieve Cannabis on 7/20/2026

On July 20, 2026, Cantor Fitzgerald updated its outlook on Trulieve Cannabis (NYSE:TRLV) with the action "Initiated Coverage", setting a "Overweight" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Cantor Fitzgerald

DateCompanyAction
7/24/2026
Avalo Therapeutics, Inc. stock logo
AVTX
Avalo Therapeutics
Reiterated Rating
7/24/2026
Molina Healthcare, Inc stock logo
MOH
Molina Healthcare
Reiterated Rating
7/24/2026
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
Reiterated Rating
7/24/2026
Tenable Holdings, Inc. stock logo
TENB
Tenable
Boost Price Target
7/24/2026
Intel Corporation stock logo
INTC
Intel
Lower Price Target
7/24/2026
Advanced Micro Devices, Inc. stock logo
AMD
Advanced Micro Devices
Reiterated Rating
More Ratings From Cantor Fitzgerald